Global new-born screening equipment sales were valued at around US$ 485 Mn at the end of 2021. The market is projected to register a 7.8% CAGR and top a valuation of US$ 1100 Mn by 2032.
“Rapid technological advancement, rise in demand for new-born diagnosis and growing need for infant’s safety are expected to uplift the new-born screening equipment market growth.”
Neonatal screening, often known as new-born screening, is a process to identify certain developmental, harmful, genetic, or metabolic problems that, if left untreated, may cause mental retardation or even death.
New-born screening is a public health initiative carried out by a number of hospitals where new-borns are checked and found with rare but critical medical disorders such as hormonal, genetic or metabolic conditions that may impede their development. In certain circumstances, the symptoms or signs are absent but the disorder can still be recognized with the help of screening. New-born screening is crucial since it can identify numerous diseases or birth defects that can be treated effectively and save a new-born's life.
Attributes
Details
New-Born Screening Equipment Market Value in 2021
US$ 485 Million
New-Born Screening Equipment Market Value in 2032
US$ 1100 Million
New-Born Screening Equipment Market CAGR (2022 to 2032)
7.8%
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
What are the Major Drivers Boosting the Demand for New-Born Screening Equipment Market?
The market for new-born screening equipment is fuelled by the prevalence of neonatal diseases has increased, leading to a dramatic increase in mortality rates. Furthermore, securing funding from government sectors for new-born screening, improving new-born screening programs, and advancements in technologies in new-born screening are all contributing factors to the market's expansion.
Additionally, rising congenital disease incidence in infants is also anticipated to raise demand for new-born screening equipment. Nowadays, the increasing infant population is one of the major drivers to boost the market expansion of new-born screening equipment. Furthermore, the development of oximeters and mass spectrometers with increased performance is anticipated to boost market expansion.
Which Region Shows Strong Growth Potential in the New-Born Screening Equipment Market?
Due to expanding testing requirements throughout all 50 states and the rising prevalence of congenital diseases, North America dominates the market for new-born screening equipment. To increase awareness, state health agencies in the U.S. have published free information and developed websites, which make it easier for parents to deal with congenital diseases. This is the most prominent reason behind the market expansion in this region.
The new-born screening equipment market in Europe is expected to expand at a rapid pace. Advancements in the healthcare industry and the presence of well-established key players boost the market expansion in this region. Due to awareness campaigns, new-born diagnostic procedure quality assurance and rising birth rate, the South and East Asia markets are displaying a lucrative growth opportunity.
Find your sweet spots for generating winning opportunities in this market.
Who are the Key Players in the New-Born Screening Equipment Market?
Some of the market players operating in the new-born screening equipment market are Gilent Technologies, Bio-Rad Laboratories, Covidien PLC, GE Life Sciences, Masimo Corporation, Natus Medical Inc., PerkinElmer Inc., Trivitron Healthcare, GE Healthcare, and ZenTech S.A.
Scope of Report
Report Attributes
Details
Growth Rate
CAGR of 7.8% 2022 to 2032
Base Year for Estimation
2021
Historical Data
2012 to 2021
Forecast Period
2022 to 2032
Qualitative Units
Revenue in USD Billion, and CAGR from 2022 to 2032
Report Coverage
Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis
Segment Covered
Product
Test Type
Technology
End User
Region
Region Covered
North America
Latin America
Europe
East Asia
South Asia
Oceania
Middle East & Africa
Key Countries Profiled
USA
Canada
Brazil
Mexico
Germany
UK
France
Spain
Italy
China
Japan
South Korea
Malaysia
Singapore
Australia
New Zealand
GCC
South Africa
Israel
Key Players
Gilent Technologies
Bio-Rad Laboratories
Covidien PLC
GE Life Sciences
Masimo Corporation
Natus Medical Inc.
PerkinElmer Inc.
Trivitron Healthcare
GE Healthcare
ZenTech S.A
Customization
Available Upon Request
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need and save 40%!
Key Segments Covered in the New-Born Screening Equipment Industry Survey
What is the Growth Outlook for the Global New-Born Screening Equipment Market?
The global new-born screening equipment market is anticipated to register a CAGR of 7.8% during the forecast period.
Who are the Key Players in the New-Born Screening Equipment Market?
The top players in the global new-born screening equipment market are Gilent Technologies, Bio-Rad Laboratories, Covidien PLC, GE Life Sciences, Masimo Corporation, Natus Medical Inc., PerkinElmer Inc., Trivitron Healthcare, GE Healthcare, and ZenTech S.A.
